MTT-Based Normalization of Glycerol Release for Accurate Quantification of Lipolysis in Primary Rat Epididymal Adipocytes

Summary

Experimental artifacts, including fluctuations in cell viability and assay interference, hinder accurate quantification of glycerol release in lipid-rich primary adipocytes. To mitigate these challenges, an MTT-based normalization strategy is used to adjust glycerol measurements for cell metabolic activity, thereby enhancing the reliability of lipolysis quantification.

Abstract

Lipolysis, a critical metabolic pathway, involves the hydrolysis of stored triglycerides into free fatty acids and glycerol. However, accurate quantification of glycerol output in lipid-rich primary adipocytes is often confounded by experimental artifacts, such as variability in cell viability and assay interference. To address these limitations, a straightforward method was established to normalize glycerol release measurements using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)-based cell viability assay. This protocol leverages the difference in specific gravity between adipocytes and aqueous solutions, enabling simultaneous quantification of lipolytic output and cell viability. In drug screening experiments, pravastatin and simvastatin significantly enhanced glycerol release from abdominal adipocytes, whereas atorvastatin and lovastatin did not significantly alter glycerol output. These findings suggest that MTT-based normalization offers a robust and convenient approach for accurately quantifying lipolysis, with potential applications in drug discovery targeting obesity and metabolic syndrome. This study underscores the need to re-evaluate conventional lipolysis assays to distinguish genuine metabolic responses from nonspecific membrane leakage.

Introduction

Adipose tissue can be divided into white adipose tissue (WAT) and brown adipose tissue (BAT)¹. WAT performs the function of excess energy storage as triglycerides, while BAT has the function of heat generation to maintain body temperature, which converts chemical energy into heat energy under the stimulation of cold¹. Adipose tissue also has endocrine function². It can secrete a variety of hormones, cytokines, and metabolites (collectively referred to as adipokines), and control the energy balance of the body by regulating food-seeking behavior from the central nervous system and the metabolic activity of surrounding tissues².

Lipolysis is a step-by-step hydrolysis process of intracellular lipids under the action of a series of lipolytic enzymes^3,4. In adipocytes, lipids are mainly stored in lipid droplets in the form of triglycerides⁵. The lipid droplets are covered with the lipid droplet-associated protein perilipin family, which prevents the hydrolysis of triglycerides by lipolytic enzymes^6,7. However, when the lipolysis signal is enhanced, expression levels of the perilipin family in adipocytes are decreased, and lipolytic enzymes enter lipid droplets^3,4. Consequently, triglycerides are decomposed into glycerol and free fatty acids^3,4,5.

Lipolysis, the breakdown of stored triglycerides into glycerol and free fatty acids, is a fundamental process in adipocyte metabolism⁸. While direct measurement of lipolysis products such as glycerol provides valuable insights, accurate quantification has been challenging, particularly in suspended primary adipocytes due to operational errors arising from differences in cell numbers among experimental groups. This study aimed to address this challenge by employing a cell viability assay to normalize the quantification of glycerol release from primary rat abdominal adipocytes. By standardizing the measurement method, the normalized glycerol release assay was applied as a potential tool for drug discovery targeting obesity and metabolic syndrome in adipocytes.

Protocol

This protocol leverages the difference in specific gravity between adipocytes and aqueous solutions to enable simultaneous measurement of glycerol release (as an indicator of lipolysis) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell viability in the same wells of a 96-well plate, thereby streamlining the experimental workflow and enhancing efficiency.

All animal procedures complied with the ARRIVE guidelines and were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 8023, revised 1978). The study protocol was approved by the Institutional Animal Care and Use Committee (approval number 202112, approved on May 5, 2021). The male Wistar rats used in this study were at least 8 weeks old with body weights of≥200 g under standard housing conditions. Epididymal white adipose tissue was collected with typical yields of 0.6-0.8 g per rat. Notably, older rats or those fed high-fat diets exhibited significantly increased white adipose tissue mass (often 1.5-3 g), requiring proportional adjustment of digestion enzyme (e.g., collagenase) concentrations to maintain consistent tissue dissociation efficiency. The exclusive use of male rats avoided potential confounding effects from female estrous cycle hormonal fluctuations. Strain selection (e.g., Sprague-Dawley, Wistar, or Long-Evans) was maintained consistently within experiments to ensure genetic uniformity in adipose tissue responses. The reagents and the equipment used are listed in the Table of Materials.

1. Isolation of primary rat abdominal adipocytes

1. Anesthetize a male adult Wistar rat with an intraperitoneal injection of 7% chloral hydrate (dissolved in distilled H₂O) (following institutionally approved protocols).
2. Confirm full anesthesia by checking for the absence of reflex responses, then make a midline abdominal incision using sterile surgical scissors.
3. Carefully remove visceral fat tissue from the left and right sides of the epididymal fat pad.
   NOTE: Epididymal adipocytes are relatively large and buoyant, which facilitates separation and analysis.
4. Transfer the collected tissue into phosphate-buffered saline (PBS; Figure 1A).
5. Wash the tissue twice with PBS to remove impurities, including adhered blood vessels and blood clots.
6. Cut the washed tissue into small pieces.

2. Purification of primary rat abdominal adipocytes

1. Incubate the dissected adipose tissue with trypsin and type II collagenase (10 mg in 10 mL trypsin solution) at 37 °C for 2 h under shaking.
2. Filter the digested adipose tissue through a cell strainer (Figure 1A).
3. Centrifuge the filtrate at 120 × g for 3 min at room temperature to remove residual enzymatic activity.
4. Transfer the suspended adipocytes (the upper white layer) into a clean tube and wash them with PBS.
5. Centrifuge the filtrate at 120 × g for 3 min at room temperature to remove PBS.
6. Incubate the filtered adipocytes (the upper white layer) in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin solution for no more than 30 min.

3. Analysis of glycerol release

1. Seed the filtered adipocytes (10⁴-10⁵ cells per well; 200 µL) in a 96-well cell culture plate.
   NOTE: Adipocytes were quantified using a standard hemocytometer. Due to the large variation in adipocyte size, some larger cells could not be accurately counted. Therefore, the cell count may not precisely reflect the actual number of adipocytes. The main goal was to achieve an even distribution of cells across wells rather than exact quantification.
2. Treat the adipocytes with 0.05% dimethyl sulfoxide (DMSO; as a control group) and 50 µM atorvastatin, pravastatin, lovastatin, and simvastatin for 4 h at 37 °C under gentle shaking.
   NOTE: These treatment conditions are provided as a reference and may be adjusted as needed based on the specific goals and design of the experiment.
3. Collect the cell culture medium (the lower red layer) to analyze glycerol release, which indicates the onset of lipolysis (Figure 1B).
4. Use a commercial glycerol release assay kit to assess adipocyte lipolysis in response to different treatments.
5. Measure absorbance at 570 nm using a microplate reader.

4. Analysis of cell viability

1. Dissolve MTT powder at a concentration of 5 mg/mL in distilled H₂O and sterilize through a 0.22 µm filter before use.
2. Following glycerol release analysis, add MTT solution (to a final 0.5 mg/mL) to the cells and incubate at 37 °C for 2 h.
3. Transfer the suspended adipocytes (the upper purple layer) into a clean tube containing DMSO for analysis of cell viability (Figure 1B).
4. Vortex briefly to solubilize purple formazan crystals formed.
5. Measure absorbance at 570 nm using a microplate reader.

5. Normalization calculation

1. Conduct all experiments in triplicate and repeat four times (n = 4).
   NOTE: For each independent experiment (n = 4), adipocytes were isolated from three rats, and each treatment condition was performed in triplicate.
2. For each treatment group, divide the glycerol release absorbance value by the corresponding cell viability absorbance value.
3. Present the data as mean ± standard deviation (SD).
   NOTE: Mean and SD were calculated using Microsoft Excel with the functions =AVERAGE(range) and =STDEV.S(range). For group comparisons, unpaired two-tailed t-tests were performed using GraphPad Prism 6 with the function t-test of Compare means.
4. Determine the statistical significance of differences between groups using Student's t-test, with a P-value less than 0.05 considered statistically significant.

Results

After preliminary drug screening, the antihyperlipidemic drug statins were used to investigate the lipolytic effects in adipocytes by the normalized glycerol release method⁹.

The impact of statins on glycerol release from primary rat abdominal adipocytes
The effect of statins on lipolysis in primary rat abdominal adipocytes was assessed by treating the cells with 50 µM of pravastatin, simvastatin, atorvastatin, lovastatin, and 0.5% DMSO for 4 h. Ana...

Discussion

This study provides a more accurate method to measure lipolysis in lipid-laden primary adipocytes. Pravastatin and simvastatin were found to induce glycerol release and reduce viability in rat epididymal adipocytes, whereas atorvastatin and lovastatin showed no significant effects. The administration of simvastatin resulted in a minimal rise in glycerol release from adipocytes. To address this issue, the MTT assay was employed to standardize the measurement of lipolysis. This approach revealed a significant enhancement i...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
0.22-µm filter	Sangon Biotech Co. Ltd.	F513165-0001	syringe filter, aquo-system, sterile
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide	Sangon Biotech Co. Ltd.	A600799-0001	1 g
96-well cell culture plates	Sangon Biotech Co. Ltd.	F603204-0001	sterile
Atorvastatin calcium salt	Cayman Chemical	10493-5	5 mg
Cell strainer	Sangon Biotech Co. Ltd.	F513450-0001	80 screen mesh
Chloral hydrate	Sangon Biotech Co. Ltd.	A500288-0250	250 g
Dimethyl sulfoxide	Sangon Biotech Co. Ltd.	A460700-0100	100 mL
Dulbecco's Modified Eagle Medium	Sangon Biotech Co. Ltd.	E600003	500 mL, high glucose, sterile
Fetal bovine serum	Sangon Biotech Co. Ltd.	E600001	100 ml, sterile
Glycerol Colorimetric Assay Kit	Cayman Chemical	10010755-96	96 wells
Lovastatin	Cayman Chemical	10010338-5	5 mg
Male adult rats	Putian University	Wistar	approximately 10-12 weeks
Penicillin-streptomycin solution	Sangon Biotech Co. Ltd.	B540732-0010	10 mL, sterile
Phosphate buffered saline	Sangon Biotech Co. Ltd.	E607009-0500	500 mL, sterile, no calcium or magnesium
Pravastatin sodium salt	Cayman Chemical	10010343-5	5 mg
Simvastatin	Cayman Chemical	10010344-5	5 mg
Trypsin solution	Sangon Biotech Co. Ltd.	E607003-0100	100 mL, without EDTA and phenol red, sterile
Type II collagenase	Sangon Biotech Co. Ltd.	A004174-0100	100 mg